Incentives must be aligned between payers and providers to transition to value-based care and physicians must have the best access to information to make the right decisions in these value-based arrangements, explains L. Patrick James, MD, chief clinical officer for health plans and policy, medical affairs, for Quest Diagnostics

On Monday, June 26, 2017, the Biden Foundation announced the launch of the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.

Senate Majority Leader Mitch McConnell (R-Kentucky) faces the challenge of bridging the gap between conservatives who want a full Obamacare repeal and Republican members facing protests at home over losing Medicaid expansion.

The Alliance for a Healthier Generation believes in giving the youth the chance to live a healthier life and will continue to create healthier options at schools despite the current administration’s restriction reductions, claims Jenny Bogard, MPH, director of healthcare strategies at the Alliance for a Healthier Generation.

As part of its new Drug Competition Action Plan, the FDA has announced it will seek to spur innovation by allowing for accelerated approvals of generic drugs without competitors. It also published a list of drugs without approved generics that could be eligible for this expedited review process.

A newly published analysis, supported by an editorial, finds that the growing prevalence of cosmetic-related adverse events may warrant stronger regulation of these products used to alter appearance.

While treatments prescribed for people with chronic pulmonary disease (COPD) and asthma–COPD overlap syndrome (ACOS) are similar, there is a need for a clearer therapeutic approach for patients with ACOS, according to a new study.

Data from multiple studies have demonstrated the efficacy of Venclexta/Venclyxto in treating relapsed or refractory chronic lymphocytic leukemia, according to Roche.

Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Grenada Health.

Several studies looked at older diabetes drugs for possible effects on breast cancer prevention, as well as the effects of diet and alcohol use on breast cancer risk.

Shortly before the Congressional Budget Office (CBO) released its score for the Senate healthcare bill, Patricia Salber, MD, MBA, of The Doctor Weighs In, and Nathan Bays, managing director at Cain Brothers, a healthcare investment bank, and policy advisor to The Health Management Academy, discussed how the Senate bill stands up to the House bill and speculation about how the CBO might score the bill.

A new study finds an association between Medicaid disenrollment in Tennessee and higher rates of late-stage breast cancer diagnoses and delays to treatment.